Here's Why You Should Add IVERIC bio (ISEE) to Your Watchlist
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small/Mid Cap Growth Strategy” fourth-quarter investor letter.
Iveric Bio Inc. (ISEE)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | HBK Investments David Costen Haley | 0 | $0 | 0% | |
| 4. | Birchview Capital Matthew Strobeck | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.62 | 25,000 | $240,500.00 | 32,500 | 2022-06-13 | Filing | |
| $16.30 | 3,069 | $50,024.70 | 7,069 | 2021-11-18 | Filing | |
| $4.00 | 62,500 | $250,000.00 | 176,854 | 2019-12-10 | Filing | |
| $3.12 | 15,000 | $46,851.00 | 114,354 | 2019-11-15 | Filing | |
| $1.48 | 25,000 | $37,000.00 | 93,105 | 2019-05-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.45 | 20,000 | $789,000.00 | 39,652 | 2023-07-03 | Filing | |
| $37.87 | 20,000 | $757,400.00 | 39,652 | 2023-06-02 | Filing | |
| $37.81 | 20,000 | $756,200.00 | 39,652 | 2023-05-02 | Filing | |
| $37.12 | 11,214 | $416,263.68 | 39,652 | 2023-05-01 | Filing | |
| $37.12 | 8,786 | $326,136.32 | 39,652 | 2023-05-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
IVERIC bio, Inc. (NASDAQ:ISEE) Q4 2022 Earnings Call Transcript
Operator: Good morning. And welcome to the IVERIC Bio Fourth Quarter 2022 Earnings Conference Call. All participants will be in listen only mode . Please note this event is being recorded.
5 Best 52-Week High Stocks To Buy Now
On December 8, Spiro Dounis at Citi initiated coverage on Energy Transfer LP (NYSE:ET) stock with a target price of $16 and a Buy rating.
5 Best Biotech Stocks Under $10
Avidity Partners Management is the largest shareholder in Nuvation Bio Inc. (NYSE:NUVB). For the second quarter, Nuvation Bio Inc.
Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Were Hedge Funds Right About IVERIC bio, Inc. (ISEE)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Fund and Insider Trading News: Viking Global Investors, Lavaca Capital, Tiger Global Management, Infrastructure Capital Advisors, Angion Biomedica Corp (ANGN), Movado Group (MOV), and More
Senvest, Impala and SRS are among the year’s top performers. Melvin, Rokos and Alphadyne among firms with steepest losses.
Hedge Funds Are Crazy About IVERIC bio, Inc. (ISEE)
In this article we will analyze whether IVERIC bio, Inc. (NASDAQ:ISEE) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Do Hedge Funds Love IVERIC bio, Inc. (ISEE)?
In this article we will take a look at whether hedge funds think IVERIC bio, Inc. (NASDAQ:ISEE) is a good investment right now.
10 Pharmaceutical Stocks to Buy According to Timothy Lynch's Stonepine Capital
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital.
Hedge Fund Resource Center Billionaire Hedge Funds
